Current Opinion in Drug Discovery & Development
Archive
Current Opinion in Drug Discovery & Development, Volume 6
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2003, 6 :1-20 (16 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2003, 6 :21-36 (16 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :37-38 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Use of microdosing to probe pharmacokinetics in humans - Is it too much for too little? DA Smith, DE Johnson, BK Park Current Opinion in Drug Discovery & Development 2003, 6 :39-40 (16 [Abstract ] [Full text ] [PDF ]
Genomic biomarkers of toxicity. FM Goodsaid Current Opinion in Drug Discovery & Development 2003, 6 :41-49 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Evaluation of the toxicological relevance of CYP3A4 induction. NJ Plant, GG Gibson Current Opinion in Drug Discovery & Development 2003, 6 :50-56 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Metabolite identification in drug discovery. AP Watt, RJ Mortshire-Smith, U Gerhard, SR Thomas Current Opinion in Drug Discovery & Development 2003, 6 :57-65 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Drug metabolism and pharmacokinetics in drug discovery. SA Roberts Current Opinion in Drug Discovery & Development 2003, 6 :66-80 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity. UA Boelsterli Current Opinion in Drug Discovery & Development 2003, 6 :81-91 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
New insights into the pharmacological and toxicological effects of thalidomide. C Meierhofer, CJ Wiedermann Current Opinion in Drug Discovery & Development 2003, 6 :92-99 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
In vitro hematotoxicity testing in drug development: A review of past, present and future applications. IN Rich Current Opinion in Drug Discovery & Development 2003, 6 :100-109 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
New understanding in cardiotoxicity. YJ King Current Opinion in Drug Discovery & Development 2003, 6 :110-116 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Informatics and multivariate analysis of toxicogenomics data. AH Salter, KC Nilsson Current Opinion in Drug Discovery & Development 2003, 6 :117-122 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Role of predictive metabolism and toxicity modeling in drug discovery - A summary of some recent advancements. AG Wilson, AC White, RA Mueller Current Opinion in Drug Discovery & Development 2003, 6 :123-128 (16 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2003, 6 :129-143 (6 [Abstract ] [Full text ] [PDF ]
Patent alert S Wan Current Opinion in Drug Discovery & Development 2003, 6 :144-156 (6 [Abstract ] [Full text ] [PDF ]
The chemistry of biological products D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :157-158 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Poxviruses as vectors for cancer immunotherapy H Kwak, H Horig, HL Kaufman Current Opinion in Drug Discovery & Development 2003, 6 :161-168 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Development of vaccines against self-antigens: The p53 paradigm S Chada, A Mhashilkar, JA Roth, D Gabrilovich Current Opinion in Drug Discovery & Development 2003, 6 :169-173 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recombinant adeno-associated virus: Formulation challenges and strategies for a gene therapy vector JF Wright, G Qu, C Tang, JM Sommer Current Opinion in Drug Discovery & Development 2003, 6 :174-178 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Therapeutic activation of caspases in cancer: A question of selectivity P Beauparlant, GC Shore Current Opinion in Drug Discovery & Development 2003, 6 :179-187 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Production of antibodies and antibody fragments in Escherichia coli and a comparison of their functions, uses and modification DP Humphreys Current Opinion in Drug Discovery & Development 2003, 6 :188-196 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Antibody-based technologies for target discovery RPC Valle, M Jendoubi Current Opinion in Drug Discovery & Development 2003, 6 :197-203 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent advances in the development of immunostimulatory oligonucleotides E Uhlmann, J Vollmer Current Opinion in Drug Discovery & Development 2003, 6 :204-217 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Zebrafish: From disease modeling to drug discovery AL Rubinstein Current Opinion in Drug Discovery & Development 2003, 6 :218-223 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Nuclear hormone receptor assays for drug discovery J Rosen, K Marschke, D Rungta Current Opinion in Drug Discovery & Development 2003, 6 :224-230 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Global gene expression analysis of single cells F Kamme, MG Erlander Current Opinion in Drug Discovery & Development 2003, 6 :231-236 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
In-depth mutation and SNP discovery using DHPLC gene scanning SL Lilleberg Current Opinion in Drug Discovery & Development 2003, 6 :237-252 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Toward third-generation aptamers: Spiegelmers and their therapeutic prospects A Vater, S Klussmann Current Opinion in Drug Discovery & Development 2003, 6 :253-261 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Direct methods to determine protein function LL Ilag Current Opinion in Drug Discovery & Development 2003, 6 :262-268 (6 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman Current Opinion in Drug Discovery & Development 2003, 6 :269-282 (20 [Abstract ] [Full text ] [PDF ]
Patent alert S Wan Current Opinion in Drug Discovery & Development 2003, 6 :283-293 (20 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :294-295 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Mining the genome for gems. P Gund, E Maliski, F Brown Current Opinion in Drug Discovery & Development 2003, 6 :296 (20 [Abstract ] [Full text ] [PDF ]
Genetic sequence data for pharmacogenomics. RB Altman Current Opinion in Drug Discovery & Development 2003, 6 :297-303 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Genome-wide prediction of disease-relevant genes and variants. J Freudenberg Current Opinion in Drug Discovery & Development 2003, 6 :304-309 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Prioritizing the human genome: Knowledge management for drug discovery. JB Golden Current Opinion in Drug Discovery & Development 2003, 6 :310-316 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
High-throughput SNP analysis for genetic association studies. G Marnellos Current Opinion in Drug Discovery & Development 2003, 6 :317-321 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Proteomic informatics: In silico methods lead to data management challenges. D Haley-Vicente, DJ Edwards Current Opinion in Drug Discovery & Development 2003, 6 :322-332 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Tools for discovery: Gene expression enterprise solutions. A Grewal, J Stockton, C Bolger Current Opinion in Drug Discovery & Development 2003, 6 :333-338 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Algorithms for high-density oligonucleotide array. Y Zhou, R Abagyan Current Opinion in Drug Discovery & Development 2003, 6 :339-345 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Integration of data and methods for genome analysis. P Durand, C Medigue, A Morgat, Y Vandenbrouck, A Viari, F Rechenmann Current Opinion in Drug Discovery & Development 2003, 6 :346-352 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Modeling the 3D structure of GPCRs: Advances and application to drug discovery. OM Becker, S Shacham, Y Marantz, S Noiman Current Opinion in Drug Discovery & Development 2003, 6 :353-361 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
The use of electronic reaction databases in process chemistry. DM Gange, J D'Antuono Current Opinion in Drug Discovery & Development 2003, 6 :362-369 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. T Langer, EM Krovat Current Opinion in Drug Discovery & Development 2003, 6 :370-376 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Enabling high-throughput discovery. M Vaschetto, T Weissbrod, D Bodle, O Guner Current Opinion in Drug Discovery & Development 2003, 6 :377-383 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Microarray expression profiling: Analysis and applications. Z Xiang, Y Yang, X Ma, W Ding Current Opinion in Drug Discovery & Development 2003, 6 :384-395 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Databases and data mining for computational vaccinology. DR Flower Current Opinion in Drug Discovery & Development 2003, 6 :396-400 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2003, 6 :401-419 (23 [Abstract ] [Full text ] [PDF ]
Patent alert S Wan Current Opinion in Drug Discovery & Development 2003, 6 :420-431 (23 [Abstract ] [Full text ] [PDF ]
The chemistry of drug design and lead optimization D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :432-433 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Letter to the Editor D Rognan Current Opinion in Drug Discovery & Development 2003, 6 :434 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The chemistry of drug design and lead optimization W Greenlee, M Desai Current Opinion in Drug Discovery & Development 2003, 6 :435-436 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Structure-based design of thrombin inhibitors R Pfau Current Opinion in Drug Discovery & Development 2003, 6 :437-450 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Inhibitors of the entry of HIV into host cells NA Meanwell, JF Kadow Current Opinion in Drug Discovery & Development 2003, 6 :451-461 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery R Netzer, U Bischoff, A Ebneth Current Opinion in Drug Discovery & Development 2003, 6 :462-469 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Predicting ADME properties and side effects: The BioPrint approach CM Krejsa, D Horvath, SL Rogalski, JE Penzotti, B Mao, F Barbosa, JC Migeon Current Opinion in Drug Discovery & Development 2003, 6 :470-480 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Lead optimization strategies as part of a drug metabolism environment WA Korfmacher Current Opinion in Drug Discovery & Development 2003, 6 :481-485 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The role of flavin-containing monooxygenases in drug metabolism and development JR Cashman Current Opinion in Drug Discovery & Development 2003, 6 :486-493 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
The impact of combinatorial chemistry on drug discovery A Lee, JG Breitenbucher Current Opinion in Drug Discovery & Development 2003, 6 :494-508 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Dynamic combinatorial chemistry: A new method for selection and preparation of synthetic receptors S Otto Current Opinion in Drug Discovery & Development 2003, 6 :509-520 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent advances in automated solid-phase carbohydrate synthesis: From screening to vaccines OJ Plante, PH Seeberger Current Opinion in Drug Discovery & Development 2003, 6 :521-525 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Silicon chemistry as a novel source of chemical diversity in drug design W Bains, R Tacke Current Opinion in Drug Discovery & Development 2003, 6 :526-543 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Crystallography, NMR and virtual screening: Integrated tools for drug discovery SW Muchmore, PJ Hajduk Current Opinion in Drug Discovery & Development 2003, 6 :544-549 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The importance of characterizing the crystal form of the drug substance during drug development SD Clas Current Opinion in Drug Discovery & Development 2003, 6 :550-560 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Antisense and RNAi: Powerful tools in drug target discovery and validation KS Lavery, TH King Current Opinion in Drug Discovery & Development 2003, 6 :561-569 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Human cell systems for drug discovery C Horrocks, R Halse, R Suzuki, PR Shepherd Current Opinion in Drug Discovery & Development 2003, 6 :570-575 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, D Rotella Current Opinion in Drug Discovery & Development 2003, 6 :577-594 (23 [Abstract ] [Full text ] [PDF ]
Patent alert S Wan Current Opinion in Drug Discovery & Development 2003, 6 :595-606 (23 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :607-608 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Editorial overview JA Lowe, CH Hill, M Duckworth Current Opinion in Drug Discovery & Development 2003, 6 :609-610 (23 [Abstract ] [Full text ] [PDF ]
Ion channel structures: A review of recent progress C Domene, S Haider, MSP Sansom Current Opinion in Drug Discovery & Development 2003, 6 :611-619 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains FJ Barrantes Current Opinion in Drug Discovery & Development 2003, 6 :620-632 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action HA Lester, C Fonck, AR Tapper, S McKinney, MI Damaj, S Balogh, J Owens, JM Wehner, AC Collins, C Labarca Current Opinion in Drug Discovery & Development 2003, 6 :633-639 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Potassium channels as therapeutic targets for autoimmune disorders H Wulff, C Beeton, KG Chandy Current Opinion in Drug Discovery & Development 2003, 6 :640-647 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The GABAA receptor gene family: New opportunities for drug development PJ Whiting Current Opinion in Drug Discovery & Development 2003, 6 :648-657 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
The role of nitric oxide in the physiological regulation of Ca2+ cycling SA Khan, JM Hare Current Opinion in Drug Discovery & Development 2003, 6 :658-666 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Molecular determinants of high-affinity drug binding to HERG channels JS Mitcheson, MD Perry Current Opinion in Drug Discovery & Development 2003, 6 :667-674 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Glycine transporter isoforms in the mammalian central nervous system: Structures, functions and therapeutic promises J Gomeza, K Ohno, H Betz Current Opinion in Drug Discovery & Development 2003, 6 :675-682 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain WM Pardridge Current Opinion in Drug Discovery & Development 2003, 6 :683-691 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Nuclear hormone receptor co-regulators OY Khan, Z Nawaz Current Opinion in Drug Discovery & Development 2003, 6 :692-701 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Androgen receptor and prostate cancer: Molecular aspects and gene expression profiling A Sommer, B Haendler Current Opinion in Drug Discovery & Development 2003, 6 :702-711 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Prospects of memory-modifying drugs that target the CREB pathway T Jackson, M Ramaswami Current Opinion in Drug Discovery & Development 2003, 6 :712-719 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Targeting IkappaB kinase for the treatment of inflammatory and other disorders JR Burke Current Opinion in Drug Discovery & Development 2003, 6 :720-728 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Novel bone-targeted Src tyrosine kinase inhibitor drug discovery WC Shakespeare, 3rd CA Metcalf, Y Wang, R Sundaramoorthi, T Keenan, M Weigele, RS Bohacek, DC Dalgarno, TK Sawyer Current Opinion in Drug Discovery & Development 2003, 6 :729-741 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Design strategies for the identification of MMP-13 and TACE inhibitors JS Skotnicki, MJ Digrandi, JI Levin Current Opinion in Drug Discovery & Development 2003, 6 :742-759 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Assays to measure the activation of membrane tyrosine kinase receptors: Focus on cellular methods LK Minor Current Opinion in Drug Discovery & Development 2003, 6 :760-765 (23 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2003, 6 :767-781 (21 [Abstract ] [Full text ] [PDF ]
Patent alert S Wan Current Opinion in Drug Discovery & Development 2003, 6 :782-796 (21 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2003, 6 :797-798 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Editorial overview RN Landau, PN Confalone, JA Grosso Current Opinion in Drug Discovery & Development 2003, 6 :799-800 (21 [Abstract ] [Full text ] [PDF ]
The Pictet-Spengler reaction in solid-phase combinatorial chemistry TE Nielsen, F Diness, M Meldal Current Opinion in Drug Discovery & Development 2003, 6 :801-814 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Solid-phase strategies for the design and synthesis of heterocyclic molecules of medicinal interest B Kundu Current Opinion in Drug Discovery & Development 2003, 6 :815-826 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Solid-phase synthesis of deglycobleomycin and bleomycin CJ Leitheiser, SM Hecht Current Opinion in Drug Discovery & Development 2003, 6 :827-837 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Searching for scalable processes: Addressing the challenges in times of increasing complexity HJ Federsel Current Opinion in Drug Discovery & Development 2003, 6 :838-847 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Protein crystallization: From HTS to kilogram-scale V Klyushnichenko Current Opinion in Drug Discovery & Development 2003, 6 :848-854 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Asymmetric hydrogenation of pharmaceutically interesting substrates IC Lennon, PH Moran Current Opinion in Drug Discovery & Development 2003, 6 :855-875 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Synthetic applications of palladium-catalyzed hydroarylation and related systems D Mitchell, H Yu Current Opinion in Drug Discovery & Development 2003, 6 :876-883 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates JA Pesti, R DiCosimo Current Opinion in Drug Discovery & Development 2003, 6 :884-901 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Microbial/enzymatic synthesis of chiral pharmaceutical intermediates RN Patel Current Opinion in Drug Discovery & Development 2003, 6 :902-920 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Rapid assembly of molecular diversity via exploitation of isocyanide-based multi-component reactions C Hulme, T Nixey Current Opinion in Drug Discovery & Development 2003, 6 :921-929 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Progress toward the synthesis of hinckdentine A WW McWhorter Jr, Y Liu Current Opinion in Drug Discovery & Development 2003, 6 :930-944 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Synthetic methodology utilized to prepare substituted imidazole p38 MAP kinase inhibitors JA Murry Current Opinion in Drug Discovery & Development 2003, 6 :945-965 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Advances in multivariate analysis in pharmaceutical process development B McKay, M Hoogenraad, EWP Damen, AA Smith Current Opinion in Drug Discovery & Development 2003, 6 :966-977 (21 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Errata Current Opinion in Drug Discovery & Development 2003, 6 :978 (27 [Abstract ] [Full text ] [PDF ]
Current Opinion in Drug Discovery & Development Volumes
previous issue
January